SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (3169)8/26/1997 1:15:00 PM
From: Tunica Albuginea   of 3991
 
Cacaito, that's good news.Nowdays we also have cryosurgery.
I believe that Muse with Actis or even better with microsurgery
that will off some of the leaky veins offers tremendous opportunity
to improve ED;especially when Muse with Prazosin comes out.
Then if a man can maintain the rest of his body in reasonable shape
with proper diet and excercise, it should be possible to improve ED
into a workable condition well into advanced age, late 70 's ??.
That could be another field in Urology to develop.If viagra is approved,
then that could also be used prior to resorting to penile vein ligation

Look up this article on Nasdaq's MM s, from Forbes:

forbes.com

Vivus, " the stealth stock ", is slowly rising, gathering converts,
building a firm base of shareholders, who ARE NOT momentum investors,
who buy on low volume because they are convinced of the fundamentals
of the stock and thus are less likely to have ' weak hands ' and dump
the stock at the first signs of market turbulence.Once the base is built
and the new EPS and good news come out, then momentum players will
come in :on top of that we'll have the MMs come in, who as described in the above
Forbes article,

" Nasdaq is especially dangerous for short-sellers. Talk to people in
stock loan departments on Wall Street, the back-office folks who
must locate shares to cover short positions. If they are frank, they
will tell tales of tricks used by professional investors, marketmakers
and even company managements to juice a stock and massacre
short-sellers."

All of the above, plus of course the giant short position of Vivus on the
Nasdaq, should be fertile ground for a nice pop anytime in the nextcouple
of months.I am going to speculate on the short position (ie add my thoughts )
when the new short interest comes out this week. Thursday?

TA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext